EWSRI is fused to POU5FI in a bone tumor with translocation t(6;22)(p21;q12)

Genes Chromosomes and Cancer

Volumn 43, Issue 2, 2005, Pages 217-222

  Yamaguchi, Shuichi ^a   Yamazaki, Yukari ^a   Ishikawa, Yuichi ^a   Kawaguchi, Noriyoshi ^b   Mukai, Hiroyuki ^c   Nakamura, Takuro ^a  

^a CANCER INSTITUTE   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c FML Laboratory   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CYTOKERATIN; GENOMIC DNA; HYBRID PROTEIN; NEURON SPECIFIC ENOLASE; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN S 100; RNA BINDING PROTEIN EWS; VIMENTIN; CALMODULIN BINDING PROTEIN; DNA BINDING PROTEIN; EWSR1 PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN; PRIMER DNA; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BONE TUMOR; CASE REPORT; CHIMERA; CHROMOSOME TRANSLOCATION; DNA BINDING; EMBRYONIC STEM CELL; EXON; FEMALE; GERM CELL; HUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; CHROMOSOME 22; CHROMOSOME 6; GENE FUSION; GENE TRANSLOCATION; GENETICS; NUCLEOTIDE SEQUENCE;

ARTIFICIAL GENE FUSION; BASE SEQUENCE; BONE NEOPLASMS; CALMODULIN-BINDING PROTEINS; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 6; DNA PRIMERS; DNA-BINDING PROTEINS; HUMANS; OCTAMER TRANSCRIPTION FACTOR-3; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 17644393140     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20171     Document Type: Article

References (23)

1. Arvand A, Denny CT. 2001. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20:5747-5754.
2. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162-165.
3. Fujino T, Suzuki A, Ito Y, Ohyashiki K, Hatano Y, Miura I, Nakamura T. 2002. Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15). Blood 99:1428-1433.
4. Gidekel S, Pizov G, Bergman Y, Pikarsky E. 2003. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4:361-370.
5. Jenkins NA, Copeland NG, Tailor BA, Bedigian HG, Lee BK. 1982. Ecotropic murine leukemia virus DNA content of normal and lymphomatous tissues of BXH-2 recombinant inbred mice. J Virol 42:379-388.
6. Jin T, Branch DR, Zhang X, Qi S, Youngson B, Goss PE. 1999. Examination of POU homeobox gene expression in human breast cancer cells. Int J Cancer 81:104-112.
7. Lessnick SL, Braun BS, Denny CT, May WA. 1995. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. Oncogene 10:423-431.
8. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW. 2003. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63:2244-2250.
9. Monk M, Holding C. 2001. Human embryonic genes re-expressed in cancer cells. Oncogene 20:8085-8091.
10. Nakamura T, Yamazaki Y, Saiki Y, Moriyama M, Largaespada DA, Jenkins NA, Copeland NG. 2000. Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product. Mol Cell Biol 20:3178-3186.
11. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391.
12. Niwa H, Miyazaki J, Smith AG. 2000. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376.
13. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ESP. 1994. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 9:3087-3097.
14. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M, Hamada H. 1990. A novel octamer binding transcription factor is differentially expressed in mouse embryonic cell. Cell 60:461-472.
15. Palmieri SL, Peter W, Heess H, Scholer HR. 1994. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev Biol 166:259-267.
16. Rabbitts TH. 1994. Chromosomal translocations in human cancer. Nature 372:143-149.
17. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, Staudt LM. 1990. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345:686-692.
18. Rossow KL, Janknecht R. 2001. The Ewing's sarcoma gene product functions as a transcriptional activator. Cancer Res 61:2690-2695.
19. Ryan AK, Rosenfeld MG. 1997. POU domain family values: flexibility, partnerships, and developmental codes. Genes Develop 11:1207-1225.
20. Scholer HR, Dressler GR, Balling R, Rohdewohld H, Gruss P. 1990. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J 9:2185-2195.
21. Tomescu O, Barr FG. 2001. Chromosomal translocations in sarcomas: prospects for therapy. Trends Mol Med 7:554-559.
22. Zhang D, Paley AJ, Childs G. 1998. The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription. J Biol Chem 273:18086-18091.
23. Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, Delattre O. 1993. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 12:4481-4487.